BeStock  
Stocks › ANAB

AnaptysBio ANAB

US equityMarket cap rank #2985
$49.20 +$0.67 (+1.38%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $49.20 0.00%
Open$48.53
Prev close$48.53
Day range$47.52 – $49.84
Volume595.5K
Market cap$1.47B
P/E (TTM)8.8
Dividend yield–

ANAB Stock News

Headlines matching AnaptysBio or the ANAB ticker, most recent first.

  • J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $60Market news · 30 Sep 2026
  • Barclays Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75Market news · 23 Sep 2026
  • Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $81Market news · 23 Sep 2026
  • UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $76Market news · 22 Sep 2026
  • TD Cowen Maintains AnaptysBio(ANAB.US) With Buy RatingMarket news · 25 Aug 2026
  • TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $70Market news · 25 Aug 2026
  • Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $93Market news · 22 Jul 2026
  • TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75Market news · 13 Jul 2026
  • H.C. Wainwright Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $95Market news · 10 Jun 2026
  • Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $93Market news · 4 May 2026
  • Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy RatingMarket news · 27 May 2026
  • J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $70Market news · 23 May 2026
  • Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $90Market news · 15 May 2026
  • A Quick Look at Today's Ratings for AnaptysBio(ANAB.US), With a Forecast Between $75 to $93Market news · 13 May 2026
  • UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $76Market news · 13 May 2026

Discussion

No comments yet — be the first to weigh in on ANAB.

Leave a comment

Scroll to Top